Canadian Task Force on Preventive Health Care

Selected References

Periodic health examination, 1995 update: 1. Screening for human papillomavirus infection in asymptomatic women

Ken Johnson, MD

  1. Miller AB, Anderson G, Brisson J et al: Report of a National Workshop on Screening for Cancer of the Cervix. CMAJ 1991; 145: 1301-1325
  2. Task Force Appointed by the Conference of Deputy Ministers of Health: Cervical cancer screening programs. I. Epidemiology and natural history of carcinoma of the cervix. CMAJ 1976; 114: 1003-1012
  3. Task Force Appointed by the Conference of Deputy Ministers of Health: Cervical cancer screening programs. II. Screening for carcinoma of the cervix. CMAJ 1976; 114: 1013-1026
  4. Task Force Appointed by the Conference of Deputy Ministers of Health: Cervical cancer screening programs. III. Components of a practical screening program for carcinoma of the cervix. CMAJ 1976; 114: 1027-1031
  5. Task Force Appointed by the Conference of Deputy Ministers of Health: Cervical cancer screening programs. IV. Relations between screening programs for carcinoma of the cervix and other screening and preventive programs in Canada. CMAJ 1976; 114: 1031-1032
  6. Task Force Appointed by the Conference of Deputy Ministers of Health: Cervical cancer screening programs. V. Conclusions and recommendations. CMAJ 1976; 114: 1033
  7. Canadian Task Force on the Periodic Health Examination: The periodic health examination. CMAJ 1979; 121: 1193-1254
  8. Schiffman MH: Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 1992; 84: 394-398
  9. Koutsky LA, Holmes KK, Critchlow MS et al: A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992; 327: 1272-1278
  10. Reeves WC, Brinton LA, Garcia M et al: Human papillomavirus infection and cervical cancer in Latin America. N Engl J Med 1989; 320: 1437-1441
  11. Schiffman MH, Bauer HM, Hoover RN et al: Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993; 85: 958-964
  12. Carmichael JA, Maskens PD: Cervical dysplasia and human papillomavirus. Am J Obstet Gynecol 1989; 160: 916-918
  13. Reeves WC, Rawls WE, Brinton LA: Epidemiology of genital papillomaviruses and cervical cancer. Rev Infect Dis 1989; II: 426-439
  14. Yu S, Miller AB, Sherman GJ: Optimising the age, number of tests, and test interval for cervical cancer screening in Canada. J Epidemiol Community Health 1982; 35: 1-10
  15. Canadian Cancer Statistics 1993, National Cancer Institute of Canada, Toronto, 1993: 14
  16. American Cancer Society: Cancer statistics, 1989. Cancer 1989; 39: 3-20
  17. Sexually transmitted diseases: extract from the annual report of the Chief Medical Officer of Health and Social Security. Genitourin Med 1985; 61: 204-207
  18. Lacey CJN, Mulcahy FM, Sutton J: Koilocyte frequency and prevalence of cervical human papilloma virus infection. Lancet 1986; 1: 557-558
  19. Armstrong BK, Allen OV, Brennan BA et al: Time trends in prevalence of cervical cytological abnormality in women attending a sexually transmitted disease clinic and their relationship to trends in sexual activity and specific infections. Br J Cancer 1986; 54: 669-675
  20. Koutsky, LA, Galloway DA, Holmes KK: Epidemiology of genital human papillomavirus infection. Epidemiol Rev 1988; 10: 122-163
  21. Meisels A, Morin C: Human papillomavirus and cancer of the uterine cervix. Gynecol Oncol 1981; 12 (2 pt 2): S111-S123
  22. Syrjanen K, Yliskoski M, Kataja V et al: Prevalence of genital human papillomavirus infections in a mass-screened Finnish female population aged 20-65 years. Int J STD AIDS 1990; 1: 410-415
  23. Syrjanen K, Hakama M, Saarikoski S et al: Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a nonselected Finnish female population. Sex Transm Dis 1990; 17: 15-19
  24. De Villiers EM, Schneider A, Miklaw H et al: Human papilloma virus infections in women with and without abnormal cervical cytology. Lancet 1987; 2: 703-705
  25. Collins RJ, Ngan HY, Hsu C: Human papillomavirus infection in the cervix of pregnant females in Hong Kong. Cytopathology 1990; 1: 147-152
  26. Rohan T, Mann V, McLaughlin J et al: PCR-detected genital papillomavirus infection: prevalence and association with risk factors for cervical cancer. Int J Cancer 1991; 49: 856-860
  27. Fisher M, Rosenfeld WD, Burk RD: Cervicovaginal human papillomavirus infection in suburban adolescents and young adults. J Pediatr 1991; 119: 821-825
  28. McKinnon KJ, Ford RM, Hunter JC: High prevalence of human papillomavirus and cervical intraepithelial neoplasia in a young Australian STD population. Int J STD AIDS 1991; 2: 276-279
  29. Van Den Brule AJ, Walboomers JM, Du Maine M et al: Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal cervical smears is associated with a history of cervical intraepithelial neoplasia. Int J Cancer 1991; 48: 404-408
  30. Horn JE, McQuillan GM, Shah KV et al: Genital human papillomavirus infections in patients attending an inner-city STD clinic. Sex Transm Dis 1991; 18: 183-187
  31. Mandal D, Haye KR, Ray TK et al: Prevalence of occult human papillomavirus infection, determined by cytology and DNA hybridization, in heterosexual men attending a genitourinary medicine clinic. Int J STD AIDS 1991; 2: 351-355
  32. Chow VT, Tay SK, Tham KM et al: Subclinical human papillomavirus infection of the male lower genital tract: colposcopy, histology and DNA analysis. Int J STD AIDS 1991; 2: 41-45
  33. Kashima H, Mounts P: Tumors of the head and neck, larynx, lung and esophagus and their possible relationship to HPV. In Syryanen K, Gissmann L, Koss LG (eds): Papillomaviruses and Human Disease, Springer-Verlag, Berlin, 1987: 138-157
  34. Rous P, Beard JW: The progression to carcinoma of virus-induced rabbit papillomas (Shope). J Exp Med 1935; 62: 523-548
  35. Jarrett WFH, McNeil PE, Grimshaw WTR et al: High incidence area of cattle cancer with a possible interaction between an environmental carcinogen and a papillomavirus. Nature 1978; 274: 215-217
  36. Gissmann L, Boshart M, Durst M et al: Presence of human papillomavirus in genital tumors. J Invest Dermatol 1984; 83: 26s-28s
  37. McNab JCM, Walkinshaw SA, Cordiner JW et al: Human papillomavirus in clinically and histologically normal tissue of patients with genital cancer. N Engl J Med 1986; 315: 1052-1058
  38. McCance DJ, Campion MJ, Clarkson PK et al: Prevalence of human papillomavirus type 16 DNA sequences in cervical epithelial neoplasia and invasive carcinoma of the cervix. Br J Obstet Gynaecol 1985; 92: 1101-1105
  39. Ritter DB, Kadish AS, Vermund SH et al: Detection of human papillomavirus deoxyribonucleic acid in exfoliated cervicovaginal cells as a predictor of cervical neoplasia in a high-risk population. Am J Obstet Gynecol 1988; 159: 1517-1525
  40. Rader JS, Rosenzweig BA, Spirtas R: Atypical squamous cells: a case-series study of the association between Papanicolaou smear results and human papillomavirus DNA genotype. J Reprod Med 1991; 36: 291-297
  41. Mitchell H, Drake M, Medley G: Prospective evaluation of risk of cervical cancer after cytological evidence of human papillomavirus infection. Lancet 1986; 1: 573-575
  42. Campion MJ, McCance DJ, Cuzick J et al: Progressive potential of mild cervical atypia: prospective cytological, colposcopic, and virological study. Lancet 1986; 2: 237-240
  43. Pagano R, Chanen W, Rome RM et al: The significance of human papilloma virus atypia ("wart virus infection") found alone on cervical cytology screening. Aust N Z J Obstet Gynaecol 1987; 27: 136-139
  44. Borst M, Butterworth CE, Baker V et al: Human papillomavirus screening for women with atypical Papanicolaou smears. J Reprod Med 1991; 36: 95-99
  45. Beutner KR: Human papilloma virus infection. J Am Acad Dermatol 1989; 20: 547-566
  46. Lorincz AT, Lancaster WD, Kurman RJ et al: Characterization of human papillomavirus in cervical neoplasias and their detection in routine clinical screening. In Peto R, zur Hausen H (eds): Viral Etiology of Cervical Cancer (Banbury Report no 21), Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1986: 225-237
  47. Reid R, Greenberg M, Jenson AB et al: Sexually transmitted papillomavirus infections. I. The anatomic distribution and pathologic grade of neoplastic lesions associated with different viral types. Am J Obstet Gynecol 1987; 156: 212-222
  48. Fuchs PG, Girardi F, Pfister H: Papillomavirus infections in cervical tumors of Austrian patients. In Steinberg BM, Brandsma JL, Taichman LB (eds): Papillomaviruses: Cancer Cells, vol 5, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1987: 297-300
  49. Syrjanen K, Vayrynen M, Saarikosoi S et al: Natural history of cervical human papillomavirus (HPV) infections based on prospective follow-up. Br J Obstet Gynaecol 1985; 92: 1086-1092
  50. Kitchener HC, Neilson L, Burnett RA et al: Prospective serial study of viral change in the cervix and correlation with human papillomavirus genome status. Br J Obstet Gynaecol 1991; 98: 1042-1048
  51. De Villiers EM, Schneider A, Gross G et al: Analysis of benign and malignant urogenital tumors for human papillomavirus infection by labelling cellular DNA. Med Microbiol Immunol (Berl) 1986; 174: 281-286
  52. Canadian Society of Cytology: The adequacy of the Papanicolaou smear. CMAJ 1994; 150: 25
  53. Spitzer M, Brandsma JL, Steinberg B et al: Detection of conditions related to human papillomavirus: comparison of cytology, colposcopy, histology, and hybridization. J Reprod Med 1990; 35: 697-703
  54. Reid R, Greenberg MD, Lorincz A et al: Should cervical cytologic testing be augmented by cervicography or human papillomavirus deoxyribonucleic acid detection? Am J Obstet Gynecol 1991; 164: 1461-1471
  55. Schneider A, Meinhardt G, de Villiers EM et al: Sensitivity of the cytologic diagnosis of cervical condyloma in comparison with HPV DNA hybridization studies. Diagn Cytopathol 1987; 3: 250-255
  56. De Villiers EM: Laboratory techniques in the investigation of human papillomavirus infection. Genitourin Med 1992; 68: 50-54
  57. Cecchini S, Iossa A, Grazzini G: Estimate of clinical human papillomavirus infection prevalence in a population-based screening. Cervix Lower Fem Genit Tract 1988; 6: 213-217
  58. Wilbur DC, Stoler MH: Testing for human papillomavirus: basic pathobiology of infection, methodologies, and implications for clinical use. Yale J Biol Med 1991; 64: 113-125
  59. Kirby P, Dunne A, King DH et al: Double-blind randomized clinical trial of self-administered Podofilox solution versus vehicle in the treatment of genital warts. Am J Med 1990; 88: 465-469
  60. Cobb MW: Human papillomavirus infection. J Am Acad Dermatol 1990; 22: 547-566
  61. Phillips TJ, Dover JS: Recent advances in dermatology. N Engl J Med 1992; 326: 167-178
  62. Ferenczy A, Mitao M, Nagai N et al: Latent papillomavirus and recurring genital warts. N Engl J Med 1985; 313: 784-788
  63. Riva JM, Sedlacek TV, Cunnane MF et al: Extended carbon dioxide laser vaporization in the treatment of subclinical papillomavirus infection of the lower genital tract. Obstet Gynecol 1989; 73: 25-30
  64. Shafi MI, Finn C, Luesley DM: Carbon dioxide laser treatment for vulval papillomatosis (vulvodynia). Br J Obstet Gynaecol 1990; 97: 1148-1150
  65. Eron LJ, Judson F, Tucker S et al: Interferon therapy for condylomata acuminata. N Engl J Med 1986; 315: 1059-1064
  66. Yliskoski M, Cantell K, Syrjanen K et al: Topical treatment with human leukocyte interferon of HPV 16 infections associated with cervical and vaginal intraepithelial neoplasias. Gynecol Oncol 1990; 36: 353-357
  67. Dunham AM, McCartney JC, McCance DJ et al: Effect of perilesional injection of alpha-interferon on cervical intra-epithelial neoplasia and associated human papillomavirus infection. J R Soc Med 1990; 83: 490-492
  68. Yliskoski M, Saarikoski S, Syrjanen K: Conization for CIN associated with human papillomavirus infection. Arch Gynecol Obstet 1991; 249: 59-65
  69. Ruge S, Felding C, Skouby SO et al: CO2-laser vaporization of human papillomavirus (HPV)-induced abnormal cervical smears. A simple and effective solution to a recurrent clinical problem. Clin Exp Obstet Gynecol 1991; 18: 99-101

Link to Full Text of this review

Link to Structured Abstract of this review

Link to Summary Table of Recommendations of this review

Link to 1994 chapter: Screening for Human Papillomavirus Infection

Top of Page

Home PageCTFPHC Home Page

Reprinted in modified format by the Canadian Task Force on Preventive Health Care
with permission.
Original Copyright © 1999 Minister of Supply and Services Canada.
For any technical issues please contact: webmaster@ctfphc.org
Last modified: November 1, 1999.